Conestoga Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Repligen
RGEN
|
+$18.6M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$15.9M |
| 3 |
CMD
Cantel Medical Corporation
CMD
|
+$15.1M |
| 4 |
Mesa Laboratories
MLAB
|
+$4.76M |
| 5 |
Dorman Products
DORM
|
+$2.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HITT
HITTITE MICROWAVE CORP
HITT
|
+$26.4M |
| 2 |
ABAX
Abaxis Inc
ABAX
|
+$14.2M |
| 3 |
FARO
Faro Technologies
FARO
|
+$13.7M |
| 4 |
BCPC
Balchem Corp
BCPC
|
+$7.13M |
| 5 |
Align Technology
ALGN
|
+$4.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.65% |
| 2 | Healthcare | 20.07% |
| 3 | Industrials | 15.68% |
| 4 | Materials | 8.38% |
| 5 | Consumer Discretionary | 6.93% |
Similar funds
Conestoga Capital Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, Conestoga Capital Advisors held 140 positions worth $1.49B, down 5.7% from $1.58B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Conestoga Capital Advisors withdrew a net $54.8M in Q2 2014, closing 10 positions and reducing 71 holdings. Its most notable exit was HITTITE MICROWAVE CORP, an estimated $26.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Conestoga Capital Advisors opened a new position in Repligen worth $23.8M.
- Conestoga Capital Advisors's largest Q2 2014 buy was Repligen: 1,044,319 shares worth $23.8M.
- Conestoga Capital Advisors added most to Cantel Medical Corporation in Q2 2014, an estimated $15.1M increase.
- Conestoga Capital Advisors's biggest Q2 2014 reduction was Abaxis Inc, cutting an estimated $14.2M.
- Conestoga Capital Advisors fully exited HITTITE MICROWAVE CORP in Q2 2014, selling an estimated $26.4M.
- Conestoga Capital Advisors's ten largest holdings make up 29% of its $1.49B portfolio in Q2 2014.
- Conestoga Capital Advisors opened 5 new positions and closed 10 in Q2 2014.
- Conestoga Capital Advisors's portfolio value fell 5.7% quarter-over-quarter to $1.49B.
Based on Conestoga Capital Advisors's 13F filing for Q2 2014, filed 8 Jul 2014.